The Design and Exogenous Delivery of siRNA for Post-transcriptional Gene Silencing

References

• Akhtar, S. and Agrawal, S. (1997) “In vivo studies with antisense oligonucleotides”, Trends Pharmacol. Sci. 18, 12–18.
   PubMed Web of Science ®Google Scholar
• Akhtar, S., Kole, R. and Juliano, R.L. (1991) “Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera”, Life Sci. 49, 1793–1801.
   PubMed Web of Science ®Google Scholar
• Akhtar, S., Hughes, M.D., Khan, A., Double, J., Hussain, M., Nawaz, Q., Bibby, M. and Sayyed, P. (2000) “The delivery of antisense therapeutics”, Adv. Drug Deliv. Rev. 44, 3–21.
   PubMed Web of Science ®Google Scholar
• Amarzguioui, M. and Prydz, H. (2004) “An algorithm for selection of functional siRNA sequences”, Biochem. Biophys. Res. Commun. 316, 1050–1058.
   PubMed Web of Science ®Google Scholar
• Amarzguioui, M., Holen, T., Babaie, E. and Prydz, H. (2003) “Tolerance for mutations and chemical modifications in a siRNA”, Nucleic Acids Res. 31, 589–595.
   PubMed Web of Science ®Google Scholar
• Audouy, S.A., de Leij, L.F., Hoekstra, D. and Molema, G. (2002) “In vivo characteristics of cationic liposomes as delivery vectors for gene therapy”, Pharm. Res. 19, 1599–1605.
   PubMed Web of Science ®Google Scholar
• Bai, X., Zhou, D., Brown, J.R., Crawford, B.E., Hennet, T. and Esko, J.D. (2001) “Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6)”, J. Biol. Chem. 276, 48189–48195.
   PubMed Web of Science ®Google Scholar
• Bartel, D.P. (2004) “MicroRNAs: genomics, biogenesis, mechanism, and function”, Cell 116, 281–297.
   PubMed Web of Science ®Google Scholar
• Bass, B.L. (2001) “RNA interference. The short answer”, Nature 411, 428–429.
   PubMed Web of Science ®Google Scholar
• Beale, G., Hollins, A.J., Benboubetra, M., Sohail, M., Fox, S.P., Benter, I. and Akhtar, S. (2003) “Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system”, J. Drug Target. 11, 449–456.
   PubMed Web of Science ®Google Scholar
• Boese, Q., Reynolds, A. and Marshall, W.A. (2004) “Basics of siRNA design and chemical synthesis”, In: Sohail, M., ed., Gene Silencing by RNA Interference: Technology and Application (CRC press, Florida, USA), pp 15–35.
   Google Scholar
• Bohula, E.A., Salisbury, A.J., Sohail, M., Playford, M.P., Riedemann, J., Southern, E.M. and Macaulay, V.M. (2003) “The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript”, J. Biol. Chem. 278, 15991–15997.
   PubMed Web of Science ®Google Scholar
• Bose, A., Guilherme, A., Robida, S.I., Nicoloro, S.M., Zhou, Q.L., Jiang, Z.Y., Pomerleau, D.P. and Czech, M.P. (2002) “Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c”, Nature 420, 821–824.
   PubMedGoogle Scholar
• Boussif, O., Lezoualc’h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.P. (1995) “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: poly- ethylenimine”, Proc. Natl Acad. Sci. USA 92, 7297–7301.
   PubMed Web of Science ®Google Scholar
• Braasch, D.A. and Corey, D.R. (2001) “Locked nucleic acid (LNA): fine- tuning the recognition of DNA and RNA”, Chem. Biol. 8, 1–7.
   PubMed Web of Science ®Google Scholar
• Braasch, D.A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M.A. and Corey, D.R. (2003) “RNA interference in mammalian cells by chemically-modified RNA”, Biochemistry 42, 7967–7975.
   PubMed Web of Science ®Google Scholar
• Braasch, D.A., Paroo, Z., Constantinescu, A., Ren, G., Oz, O.K., Mason, R.P. and Corey, D.R. (2004) “Biodistribution of phosphodiester and phosphorothioate siRNA”, Bioorg. Med. Chem. Lett. 14, 1139–1143.
   PubMed Web of Science ®Google Scholar
• Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L. and Iggo, R. (2003) “Induction of an interferon response by RNAi vectors in mammalian cells”, Nat. Genet. 34, 263–264.
   PubMed Web of Science ®Google Scholar
• Caplen, N.J. (2002) “A new approach to the inhibition of gene expression”, Trends Biotechnol. 20, 49–51.
   PubMed Web of Science ®Google Scholar
• Capodici, J., Kariko, K. and Weissman, D. (2002) “Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference”, J. Immunol. 169, 5196–5201.
   PubMed Web of Science ®Google Scholar
• Caudy, A.A., Myers, M., Hannon, G.J. and Hammond, S.M. (2002) “Fragile X-related protein and VIG associate with the RNA interference machinery”, Genes Dev. 16, 2491–2496.
   PubMed Web of Science ®Google Scholar
• Caudy, A.A., Ketting, R.F., Hammond, S.M., Denli, A.M., Bathoorn, A.M., Tops, B.B., Silva, J.M., Myers, M.M., Hannon, G.J. and Plasterk, R.H. (2003) “A micrococcal nuclease homologue in RNAi effector complexes”, Nature 425, 411–414.
   PubMed Web of Science ®Google Scholar
• Chi, J.T., Chang, H.Y., Wang, N.N., Chang, D.S., Dunphy, N. and Brown, P.O. (2003) “Genomewide view of gene silencing by small interfering RNAs”, Proc. Natl Acad. Sci. USA 100, 6343–6346.
   PubMed Web of Science ®Google Scholar
• Chiu, Y.L. and Rana, T.M. (2002) “RNAi in human cells: basic structural and functional features of small interfering RNA”, Mol. Cell 10, 549–561.
   PubMed Web of Science ®Google Scholar
• Chiu, Y.L. and Rana, T.M. (2003) “siRNA function in RNAi: a chemical modification analysis”, RNA 9, 1034–1048.
   Google Scholar
• Chung, H.K., Yi, Y.W., Jung, N.C., Kim, D., Suh, J.M., Kim, H., Park, K.C., Song, J.H., Kim, D.W., Hwang, E.S., Yoon, S.H., Bae, Y.S., Kim, J.M., Bae, I. and Shong, M. (2003) “CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle”, J. Biol. Chem. 278, 28079–28088.
   Google Scholar
• Coulson, J.M., Poyner, D.R., Chantry, A., Irwin, W.J. and Akhtar, S. (1996) “A nonantisense sequence-selective effect of a phosphoro- thioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells”, Mol. Pharmacol. 50, 314–325.
   PubMed Web of Science ®Google Scholar
• Czauderna, F., Fechtner, M., Dames, S., Aygun, H., Klippel, A., Pronk, G.J., Giese, K. and Kaufmann, J. (2003) “Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells”, Nucleic Acids Res. 31, 2705–2716.
   PubMed Web of Science ®Google Scholar
• Dass, C.R. and Burton, M.A. (2003) “Modified microplex vector enhances transfection of cells in culture while maintaining tumour- selective gene delivery in-vivo”, J. Pharm. Pharmacol. 55, 19–25.
   PubMed Web of Science ®Google Scholar
• Donze, O. and Picard, D. (2002) “RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase”, Nucleic Acids Res. 30, e46.
   PubMed Web of Science ®Google Scholar
• Dorn, G., Patel, S., Wotherspoon, G., Hemmings-Mieszczak, M., Barclay, J., Natt, F.J., Martin, P., Bevan, S., Fox, A., Ganju, P., Wishart, W. and Hall, J. (2004) “siRNA relieves chronic neuropathic pain”, Nucleic Acids Res. 32, e49.
   PubMed Web of Science ®Google Scholar
• Dorsett, Y. and Tuschl, T. (2004) “siRNAs: applications in functional genomics and potential as therapeutics”, Nat. Rev. Drug Discov. 3, 318–329.
   PubMed Web of Science ®Google Scholar
• Drin, G., Cottin, S., Blanc, E., Rees, A.R. and Temsamani, J. (2003) “Studies on the internalization mechanism of cationic cell- penetrating peptides”, J. Biol. Chem. 278, 31192–31201.
   PubMed Web of Science ®Google Scholar
• Duxbury, M.S., Ito, H., Benoit, E., Zinner, M.J., Ashley, S.W. and Whang, E.E. (2003) “RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity”, Biochem. Biophys. Res. Commun. 311, 786–792.
   PubMed Web of Science ®Google Scholar
• Dykxhoorn, D.M., Novina, C.D. and Sharp, P.A. (2003) “Killing the messenger: short RNAs that silence gene expression”, Nat. Rev. Mol. Cell Biol. 4, 457–467.
   PubMed Web of Science ®Google Scholar
• Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. (2001a) “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells”, Nature 411, 494–498.
   PubMed Web of Science ®Google Scholar
• Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001b) “RNA interference is mediated by 21- and 22-nucleotide RNAs”, Genes Dev. 15, 188–200.
   PubMed Web of Science ®Google Scholar
• Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W. and Tuschl, T. (2001c) “Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate”, EMBO J. 20, 6877–6888.
   PubMed Web of Science ®Google Scholar
• Elbashir, S.M., Harborth, J., Weber, K. and Tuschl, T. (2002) “Analysis of gene function in somatic mammalian cells using small interfering RNAs”, Methods 26, 199–213.
   PubMed Web of Science ®Google Scholar
• Farhood, H., Bottega, R., Epand, R.M. and Huang, L. (1992) “Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity”, Biochim. Biophys. Acta 1111, 239–246.
   PubMed Web of Science ®Google Scholar
• Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B. and Barsoum, J. (1994) “Tat-mediated delivery of heterologous proteins into cells”, Proc. Natl Acad. Sci. USA 91, 664–668.
   PubMed Web of Science ®Google Scholar
• Fell, P.L., Hudson, A.J., Reynolds, M.A., Usman, N. and Akhtar, S. (1997) “Cellular uptake properties of a 20 -amino/20 -O-methyl- modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA”, Antisense Nucleic Acid Drug Dev. 7, 319–326.
   PubMedGoogle Scholar
• Filion, M.C. and Phillips, N.C. (1997) “Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells”, Biochim. Biophys. Acta 1329, 345–356.
   PubMed Web of Science ®Google Scholar
• Filleur, S., Courtin, A., Ait-Si-Ali, S., Guglielmi, J., Merle, C., Harel- Bellan, A., Clezardin, P. and Cabon, F. (2003) “SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth”, Cancer Res. 63, 3919–3922.
   PubMed Web of Science ®Google Scholar
• Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) “Potent and specific genetic interference by double- stranded RNA in Caenorhabditis elegans”, Nature 391, 806–811.
   PubMed Web of Science ®Google Scholar
• Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F. and Giacca, M. (2003) “Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins”, J. Biol. Chem. 278, 34141–34149.
   PubMed Web of Science ®Google Scholar
• Gaggar, A., Shayakhmetov, D.M. and Lieber, A. (2003) “CD46 is a cellular receptor for group B adenoviruses”, Nat. Med. 9, 1408–1412.
   PubMed Web of Science ®Google Scholar
• Gan, L., Anton, K.E., Masterson, B.A., Vincent, V.A., Ye, S. and Gonzalez-Zulueta, M. (2002) “Specific interference with gene expression and gene function mediated by long dsRNA in neural cells”, J. Neurosci. Methods 121, 151–157.
   PubMed Web of Science ®Google Scholar
• Geary, R.S., Yu, R.Z. and Levin, A.A. (2001) “Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides”, Curr. Opin. Investig. Drugs 2, 562–573.
   PubMedGoogle Scholar
• Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O. and Galun, E. (2003) “Small interfering RNA inhibits hepatitis B virus replication in mice”, Mol. Ther. 8, 769–776.
   PubMed Web of Science ®Google Scholar
• Haensler, J. and Szoka, F.C., Jr. (1993) “Polyamidoamine cascade polymers mediate efficient transfection of cells in culture”, Bioconjug. Chem. 4, 372–379.
   PubMed Web of Science ®Google Scholar
• Hall, J. (2004) “Unravelling the general properties of siRNAs strength in numbers and lessons from the past”, Nat. Rev. Genet. 5, 552–557.
   PubMed Web of Science ®Google Scholar
• Hammond, S.M., Bernstein, E., Beach, D. and Hannon, G.J. (2000) “An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells”, Nature 404, 293–296.
   PubMed Web of Science ®Google Scholar
• Hammond, S.M., Boettcher, S., Caudy, A.A., Kobayashi, R. and Hannon, G.J. (2001) “Argonaute2, a link between genetic and biochemical analyses of RNAi”, Science 293, 1146–1150.
   PubMed Web of Science ®Google Scholar
• Harborth, J., Elbashir, S.M., Vandenburgh, K., Manninga, H., Scaringe, S.A., Weber, K. and Tuschl, T. (2003) “Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing”, Antisense Nucleic Acid Drug Dev. 13, 83–105.
   PubMedGoogle Scholar
• Hohjoh, H. (2002) “RNA interference (RNA(i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells”, FEBS Lett. 521, 195–199.
   PubMed Web of Science ®Google Scholar
• Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E. and Prydz, H. (2002) “Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor”, Nucleic Acids Res. 30, 1757–1766.
   PubMed Web of Science ®Google Scholar
• Hollins, A.J., Benboubetra, M., Omidi, Y., Zinselmeyer, B.H., Schatzlein, A.G., Uchegbu, I.F. and Akhtar, S. (2004) “Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor”, Pharm. Res. 21, 458–466.
   PubMed Web of Science ®Google Scholar
• Huang, Y.Z., Zang, M., Xiong, W.C., Luo, Z. and Mei, L. (2003) “Erbin suppresses the MAP kinase pathway”, J. Biol. Chem. 278, 1108–1114.
   PubMed Web of Science ®Google Scholar
• Huang, H., Zegarra-Moro, O.L., Benson, D. and Tindall, D.J. (2004) “Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells”, Oncogene 23, 2161–2176.
   PubMed Web of Science ®Google Scholar
• Hudson, A.J., Normand, N., Ackroyd, J. and Akhtar, S. (1999) “Cellular delivery of hammerhead ribozymes conjugated to a transferrin receptor antibody”, Int. J. Pharm. 182, 49–58.
   PubMed Web of Science ®Google Scholar
• Hughes, J., Astriab, A., Yoo, H., Alahari, S., Liang, E., Sergueev, D., Shaw, B.R. and Juliano, R.L. (2000) “In vitro transport and delivery of antisense oligonucleotides”, Methods Enzymol. 313, 342–358.
   PubMed Web of Science ®Google Scholar
• Hughes, M.D., Hussain, M., Nawaz, Q., Petch, A.K., Sayyed, P. and Akhtar, S. (2001) “Cellular delivery of antisense oligonucleotides and ribozymes”, Drug Discov. Today 6, 303–315.
   PubMed Web of Science ®Google Scholar
• Ishizuka, A., Siomi, M.C. and Siomi, H. (2002) “A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins”, Genes Dev. 16, 2497–2508.
   PubMed Web of Science ®Google Scholar
• Islam, A., Handley, S.L., Thompson, K.S. and Akhtar, S. (2000) “Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems”, J. Drug Target. 7, 373–382.
   PubMed Web of Science ®Google Scholar
• Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G. and Linsley, P.S. (2003) “Expression profiling reveals off-target gene regulation by RNAi”, Nat. Biotechnol. 21, 635–637.
   PubMed Web of Science ®Google Scholar
• Ji, J., Wernli, M., Klimkait, T. and Erb, P. (2003) “Enhanced gene silencing by the application of multiple specific small interfering RNAs”, FEBS Lett. 552, 247–252.
   PubMed Web of Science ®Google Scholar
• Karmali, P.P., Kumar, V.V. and Chaudhuri, A. (2004) “Design, syntheses and in vitro gene delivery efficacies of novel mono-, di- and trilysinated cationic lipids: a structure-activity investigation”, J. Med. Chem. 47, 2123–2132.
   PubMed Web of Science ®Google Scholar
• Kawasaki, A.M., Casper, M.D., Freier, S.M., Lesnik, E.A., Zounes, M.C., Cummins, L.L., Gonzalez, C. and Cook, P.D. (1993) “Uniformly modified 20 -deoxy-20 -fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets”, J. Med. Chem. 36, 831–841.
   PubMed Web of Science ®Google Scholar
• Kennedy, S., Wang, D. and Ruvkun, G. (2004) “A conserved siRNA- degrading RNase negatively regulates RNA interference in C. elegans”, Nature 427, 645–649.
   PubMed Web of Science ®Google Scholar
• Kennerdell, J.R. and Carthew, R.W. (1998) “Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway”, Cell 95, 1017–1026.
   PubMed Web of Science ®Google Scholar
• Khan, A., Sommer, W., Fuxe, K. and Akhtar, S. (2000) “Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain”, J. Drug Target. 8, 319–334.
   PubMed Web of Science ®Google Scholar
• Khan, A., Benboubetra, M., Wooi, K.N., Fox, S., Beck, G. and Akhtar, S. (2004) “Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies”, J. Drug Target., in press.
   Google Scholar
• Khvorova, A., Reynolds, A. and Jayasena, S.D. (2003) “Functional siRNAs and miRNAs exhibit strand bias”, Cell 115, 209–216.
   PubMed Web of Science ®Google Scholar
• Kretschmer-Kazemi Far, R. and Sczakiel, G. (2003) “The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides”, Nucleic Acids Res. 31, 4417–4424.
   PubMed Web of Science ®Google Scholar
• Krichevsky, A.M. and Kosik, K.S. (2002) “RNAi functions in cultured mammalian neurons”, Proc. Natl Acad. Sci. USA 99, 11926–11929. Kumar, R., Conklin, D.S. and Mittal, V. (2003) “High-throughput selection of effective RNAi probes for gene silencing”, Genome Res. 13, 2333–2340.
   Google Scholar
• Laposa, R.R., Feeney, L. and Cleaver, J.E. (2003) “Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H”, Cancer Res. 63, 3909–3912.
   PubMed Web of Science ®Google Scholar
• Lee, J.C., Schickling, O., Stegh, A.H., Oshima, R.G., Dinsdale, D., Cohen, G.M. and Peter, M.E. (2002) “DEDD regulates degradation of intermediate filaments during apoptosis”, J. Cell Biol. 158, 1051–1066.
   PubMed Web of Science ®Google Scholar
• Leirdal, M. and Sioud, M. (2002) “Gene silencing in mammalian cells by preformed small RNA duplexes”, Biochem. Biophys. Res. Commun. 295, 744–748.
   PubMed Web of Science ®Google Scholar
• Leu, Y.W., Rahmatpanah, F., Shi, H., Wei, S.H., Liu, J.C., Yan, P.S. and Huang, T.H. (2003) “Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation”, Cancer Res. 63, 6110–6115.
   PubMed Web of Science ®Google Scholar
• Lewis, K.J., Irwin, W.J. and Akhtar, S. (1998) “Development of a sustained-release biodegradable polymer system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro”, J. Drug Target. 5, 291–302.
   PubMed Web of Science ®Google Scholar
• Lewis, D.L., Hagstrom, J.E., Loomis, A.G., Wolff, J.A. and Herweijer, H. (2002) “Efficient delivery of siRNA for inhibition of gene expression in postnatal mice”, Nat. Genet. 32, 107–108.
   PubMed Web of Science ®Google Scholar
• Lieberman, J., Song, E., Lee, S.K. and Shankar, P. (2003) “Interfering with disease: opportunities and roadblocks to harnessing RNA interference”, Trends Mol. Med. 9, 397–403.
   PubMed Web of Science ®Google Scholar
• Lindgren, M., Hallbrink, M., Prochiantz, A. and Langel, U. (2000) “Cell- penetrating peptides”, Trends Pharmacol. Sci. 21, 99–103.
   PubMed Web of Science ®Google Scholar
• Lingel, A., Simon, B., Izaurralde, E. and Sattler, M. (2003) “Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain”, Nature 426, 465–469.
   PubMed Web of Science ®Google Scholar
• Liu, Q., Rand, T.A., Kalidas, S., Du, F., Kim, H.E., Smith, D.P. and Wang, X. (2003) “R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway”, Science 301, 1921–1925.
   PubMedGoogle Scholar
• Loke, S.L., Stein, C., Zhang, X., Avigan, M., Cohen, J. and Neckers, L.M. (1988) “Delivery of c-myc antisense phosphorothioate oligodeoxy- nucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis”, Curr. Top. Microbiol. Immunol. 141, 282–289.
   PubMed Web of Science ®Google Scholar
• Lundberg, P. and Langel, U. (2003) “A brief introduction to cell- penetrating peptides”, J. Mol. Recognit. 16, 227–233.
   PubMed Web of Science ®Google Scholar
• Luo, K.Q. and Chang, D.C. (2004) “The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region”, Biochem. Biophys. Res. Commun. 318, 303–310.
   PubMed Web of Science ®Google Scholar
• Makimura, H., Mizuno, T.M., Mastaitis, J.W., Agami, R. and Mobbs, C.V. (2002) “Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake”, BMC Neurosci. 3, 18.
   PubMed Web of Science ®Google Scholar
• Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R. and Tuschl, T. (2002) “Single-stranded antisense siRNAs guide target RNA cleavage in RNAi”, Cell 110, 563–574.
   PubMed Web of Science ®Google Scholar
• Martinez, J. and Tuschl, T. (2004) “RISC is a 50 phosphomonoester- producing RNA endonuclease”, Genes Dev. 18, 975–980.
   PubMed Web of Science ®Google Scholar
• Massaro, D., Massaro, G.D. and Clerch, L.B. (2004) “Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice”, Am. J. Physiol. Lung Cell. Mol. Physiol., in press. Mathews, D.H., Sabina, J., Zuker, M. and Turner, D.H. (1999) “Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure”, J. <i>Mol. Biol. 288, 911–940.
   Google Scholar
• Maurer-Stroh, S., Dickens, N.J., Hughes-Davies, L., Kouzarides, T., Eisenhaber, F. and Ponting, C.P. (2003) “The Tudor domain Royal Family: Tudor, plant Agenet, Chromo, PWWP and MBT domains”, Trends Biochem. Sci. 28, 69–74.
   PubMed Web of Science ®Google Scholar
• McCaffrey, A.P., Meuse, L., Pham, T.T., Conklin, D.S., Hannon, G.J. and Kay, M.A. (2002) “RNA interference in adult mice”, Nature 418, 38–39.
   PubMed Web of Science ®Google Scholar
• McManus, M.T. and Sharp, P.A. (2002) “Gene silencing in mammals by small interfering RNAs”, Nat. Rev. Genet. 3, 737–747.
   PubMed Web of Science ®Google Scholar
• McManus, M.T., Haines, B.B., Dillon, C.P., Whitehurst, C.E., van Parijs, L., Chen, J. and Sharp, P.A. (2002) “Small interfering RNA-mediated gene silencing in T lymphocytes”, J. Immunol. 169, 5754–5760.
   PubMed Web of Science ®Google Scholar
• Medema, R.H. (2004) “Optimizing RNA interference for application in mammalian cells”, Biochem. J., in press.
   Google Scholar
• Miyagishi, M., Matsumoto, S. and Taira, K. (2004) “Generation of an shRNAi expression library against the whole human transcripts”, Virus Res. 102, 117–124.
   PubMed Web of Science ®Google Scholar
• Mohmmed, A., Dasaradhi, P.V., Bhatnagar, R.K., Chauhan, V.S. and Malhotra, P. (2003) “In vivo gene silencing in Plasmodium berghei— a mouse malaria model”, Biochem. Biophys. Res. Commun. 309, 506–511.
   PubMed Web of Science ®Google Scholar
• Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. and Freier, S.M. (1993) “Evaluation of 20 -modified oligonucleotides containing 20 -deoxy gaps as antisense inhibitors of gene expression”, J. Biol. Chem. 268, 14514–14522.
   PubMed Web of Science ®Google Scholar
• Monia, B.P., Johnston, J.F., Geiger, T., Muller, M. and Fabbro, D. (1996) “Antitumor activity of a phosphorothioate antisense oligodeoxy- nucleotide targeted against C-raf kinase”, Nat. Med. 2, 668–675.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., Vidal, P., Chaloin, L., Heitz, F. and Divita, G. (1997) “A new peptide vector for efficient delivery of oligonucleotides into mammalian cells”, Nucleic Acids Res. 25, 2730–2736.
   PubMed Web of Science ®Google Scholar
• Morris, M.C., Chaloin, L., Mery, J., Heitz, F. and Divita, G. (1999) “A novel potent strategy for gene delivery using a single peptide vector as a carrier”, Nucleic Acids Res. 27, 3510–3517.
   PubMed Web of Science ®Google Scholar
• Muratovska, A. and Eccles, M.R. (2004) “Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells”, FEBS Lett. 558, 63–68.
   PubMed Web of Science ®Google Scholar
• Nagahiro, I., Mora, B.N., Boasquevisque, C.H., Scheule, R.K. and Patterson, G.A. (2000) “Toxicity of cationic liposome-DNA complex in lung isografts”, Transplantation 69, 1802–1805.
   PubMed Web of Science ®Google Scholar
• Nikcevic, G., Kovacevic-Grujicic, N. and Stevanovic, M. (2003) “Improved transfection efficiency of cultured human cells”, Cell Biol. Int. 27, 735–737.
   PubMed Web of Science ®Google Scholar
• North, B.J., Marshall, B.L., Borra, M.T., Denu, J.M. and Verdin, E. (2003) “The human Sir2 ortholog, SIRT2, is an NADþ -dependent tubulin deacetylase”, Mol. Cell 11, 437–444.
   PubMed Web of Science ®Google Scholar
• Nykanen, A., Haley, B. and Zamore, P.D. (2001) “ATP requirements and small interfering RNA structure in the RNA interference pathway”, Cell 107, 309–321.
   PubMed Web of Science ®Google Scholar
• Oelgeschlager, M., Larrain, J., Geissert, D. and De Robertis, E.M. (2000) “The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling”, Nature 405, 757–763.
   PubMed Web of Science ®Google Scholar
• Omidi, Y., Hollins, A.J., Benboubetra, M., Drayton, R., Benter, I.F. and Akhtar, S. (2003) “Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine- induced gene expression changes in human epithelial cells”, J. Drug Target. 11, 311–323.
   PubMed Web of Science ®Google Scholar
• Parrish, S., Fleenor, J., Xu, S., Mello, C. and Fire, A. (2000) “Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference”, Mol. Cell 6, 1077–1087.
   PubMed Web of Science ®Google Scholar
• Pedroso de Lima, M.C., Simoes, S., Pires, P., Faneca, H. and Duzgunes, N. (2001) “Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications”, Adv. Drug Deliv. Rev. 47, 277– 294.
   Google Scholar
• Persengiev, S.P., Zhu, X. and Green, M.R. (2004) “Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs)”, RNA 10, 12–18.
   PubMed Web of Science ®Google Scholar
• Petch, A.K., Sohail, M., Hughes, M.D., Benter, I., Darling, J., Southern, E.M. and Akhtar, S. (2003) “Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides”, Biochem. Pharmacol. 66, 819–830.
   PubMed Web of Science ®Google Scholar
• Pham, J.W., Pellino, J.L., Lee, Y.S., Carthew, R.W. and Sontheimer, E.J. (2004) “A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila”, Cell 117, 83–94.
   PubMed Web of Science ®Google Scholar
• Pleyer, U., Groth, D., Hinz, B., Keil, O., Bertelmann, E., Rieck, P. and Reszka, R. (2001) “Efficiency and toxicity of liposome- mediated gene transfer to corneal endothelial cells”, Exp. Eye Res. 73, 1– 7.
   PubMed Web of Science ®Google Scholar
• Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J.X., Xu, X.J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T. and Langel, U. (1998) “Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo”, Nat. Biotechnol. 16, 857–861.
   PubMed Web of Science ®Google Scholar
• Porter, L.A., Dellinger, R.W., Tynan, J.A., Barnes, E.A., Kong, M., Lenormand, J.L. and Donoghue, D.J. (2002) “Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2”, J. Cell Biol. 157, 357–366.
   PubMed Web of Science ®Google Scholar
• Potente, M., Fisslthaler, B., Busse, R. and Fleming, I. (2003) “11,12- Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1”, J. Biol. Chem. 278, 29619–29625.
   PubMed Web of Science ®Google Scholar
• Puebla, I., Esseghir, S., Mortlock, A., Brown, A., Crisanti, A. and Low, W. (2003) “A recombinant H1 histone-based system for efficient delivery of nucleic acids”, J. Biotechnol. 105, 215–226.
   PubMed Web of Science ®Google Scholar
• Reich, S.J., Fosnot, J., Kuroki, A., Tang, W., Yang, X., Maguire, A.M., Bennett, J. and Tolentino, M.J. (2003) “Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascu- larization in a mouse model”, Mol. Vis. 9, 210–216.
   PubMed Web of Science ®Google Scholar
• Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S. and Khvorova, A. (2004) “Rational siRNA design for RNA interference”, Nat. Biotechnol. 22, 326–330.
   PubMed Web of Science ®Google Scholar
• Richard, J.P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M.J., Chernomordik, L.V. and Lebleu, B. (2003) “Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake”, J. Biol. Chem. 278, 585–590.
   PubMed Web of Science ®Google Scholar
• Rockwell, P., O’Connor, W.J., King, K., Goldstein, N.I., Zhang, L.M. and Stein, C.A. (1997) “Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides”, Proc. Natl Acad. Sci. USA 94, 6523–6528.
   PubMed Web of Science ®Google Scholar
• Sands, H., Gorey-Feret, L.J., Cocuzza, A.J., Hobbs, F.W., Chidester, D. and Trainor, G.L. (1994) “Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate”, Mol. Pharmacol. 45, 932–943.
   PubMed Web of Science ®Google Scholar
• Schiffelers, R.M., Woodle, M.C. and Scaria, P. (2004) “Pharmaceutical prospects for RNA interference”, Pharm. Res. 21, 1–7.
   PubMed Web of Science ®Google Scholar
• Schwarz, D.S., Hutvagner, G., Haley, B. and Zamore, P.D. (2002) “Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways”, Mol. Cell 10, 537–548.
   PubMed Web of Science ®Google Scholar
• Schwarz, D.S., Hutvagner, G., Du, T., Xu, Z., Aronin, N. and Zamore, P.D. (2003) “Asymmetry in the assembly of the RNAi enzyme complex”, Cell 115, 199–208.
   PubMed Web of Science ®Google Scholar
• Schwarz, D.S., Tomari, Y. and Zamore, P.D. (2004) “The RNA-induced silencing complex is a Mg2þ -dependent endonuclease”, Curr. Biol. 14, 787–791.
   PubMed Web of Science ®Google Scholar
• Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D.N. and Fesik, S.W. (2003) “Specificity of short interfering RNA determined through gene expression signatures”, Proc. Natl Acad. Sci. USA 100, 6347–6352.
   PubMed Web of Science ®Google Scholar
• Shoji, Y., Akhtar, S., Periasamy, A., Herman, B. and Juliano, R.L. (1991) “Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages”, Nucleic Acids Res. 19, 5543–5550.
   PubMed Web of Science ®Google Scholar
• Simeoni, F., Morris, M.C., Heitz, F. and Divita, G. (2003) “Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells”, Nucleic Acids Res. 31, 2717–2724.
   PubMed Web of Science ®Google Scholar
• Sioud, M. (2004) “Therapeutic siRNAs”, Trends Pharmacol. Sci. 25, 22–28.
   PubMed Web of Science ®Google Scholar
• Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. and Williams, B.R. (2003) “Activation of the interferon system by short-interfering RNAs”, Nat. Cell Biol. 5, 834–839.
   PubMed Web of Science ®Google Scholar
• Smith, L., Andersen, K.B., Hovgaard, L. and Jaroszewski, J.W. (2000) “Rational selection of antisense oligonucleotide sequences”, Eur. J. Pharm. Sci. 11, 191–198.
   PubMed Web of Science ®Google Scholar
• Sohail, M. and Southern, E.M. (2000) “Selecting optimal antisense reagents”, Adv. Drug Deliv. Rev. 44, 23–34.
   PubMed Web of Science ®Google Scholar
• Sohail, M., Hochegger, H., Klotzbucher, A., Guellec, R.L., Hunt, T. and Southern, E.M. (2001) “Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo”, Nucleic Acids Res. 29, 2041–2051.
   PubMed Web of Science ®Google Scholar
• Song, E., Lee, S.K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P. and Lieberman, J. (2003a) “RNA interference targeting Fas protects mice from fulminant hepatitis”, Nat. Med. 9, 347–351.
   PubMed Web of Science ®Google Scholar
• Song, J.J., Liu, J., Tolia, N.H., Schneiderman, J., Smith, S.K., Martienssen, R.A., Hannon, G.J. and Joshua-Tor, L. (2003b) “The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes”, Nat. Struct. Biol. 10, 1026–1032.
   PubMedGoogle Scholar
• Sorensen, D.R., Leirdal, M. and Sioud, M. (2003) “Gene silencing by systemic delivery of synthetic siRNAs in adult mice”, J. Mol. Biol. 327, 761–766.
   PubMed Web of Science ®Google Scholar
• Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. and Schreiber, R.D. (1998) “How cells respond to interferons”, Annu. Rev. Biochem. 67, 227–264.
   PubMed Web of Science ®Google Scholar
• Tarahovsky, Y.S. and Ivanitsky, G.R. (1998) “Structural polymorphism of lipids and effectiveness of gene delivery”, Biochemistry (Mosc) 63, 607–618.
   PubMed Web of Science ®Google Scholar
• Theobald, D.L., Mitton-Fry, R.M. and Wuttke, D.S. (2003) “Nucleic acid recognition by OB-fold proteins”, Annu. Rev. Biophys. Biomol. Struct. 32, 115–133.
   PubMedGoogle Scholar
• Theodore, L., Derossi, D., Chassaing, G., Llirbat, B., Kubes, M., Jordan, P., Chneiweiss, H., Godement, P. and Prochiantz, A. (1995) “Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse”, J. Neurosci. 15, 7158–7167.
   PubMed Web of Science ®Google Scholar
• Tijsterman, M., Ketting, R.F. and Plasterk, R.H. (2002) “The genetics of RNAsilencing”, Annu. Rev. Genet. 36, 489–519.
   PubMed Web of Science ®Google Scholar
• Tolentino, M.J., Brucker, A.J., Fosnot, J., Ying, G.S., Wu, I.H., Malik, G., Wan, S. and Reich, S.J. (2004) “Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser- induced model of choroidal neovascularization”, Retina 24, 132–138.
   PubMed Web of Science ®Google Scholar
• Torchilin, V.P., Rammohan, R., Weissig, V. and Levchenko, T.S. (2001) “TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors”, Proc. Natl Acad. Sci. USA 98, 8786–8791.
   PubMed Web of Science ®Google Scholar
• Troussard, A.A., Mawji, N.M., Ong, C., Mui, A., St -Arnaud, R. and Dedhar, S. (2003) “Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation”, J. Biol. Chem. 278, 22374–22378.
   Google Scholar
• Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H. and Sabe, H. (2002) “Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration”, J. Cell Biol. 159, 673–683.
   PubMed Web of Science ®Google Scholar
• Ui-Tei, K., Naito, Y., Takahashi, F., Haraguchi, T., Ohki-Hamazaki, H., Juni, A., Ueda, R. and Saigo, K. (2004) “Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference”, Nucleic Acids Res. 32, 936–948.
   PubMed Web of Science ®Google Scholar
• Usui, I., Imamura, T., Huang, J., Satoh, H. and Olefsky, J.M. (2003) “Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes”, J. Biol. Chem. 278, 13765–13774.
   PubMed Web of Science ®Google Scholar
• Verma, U.N., Surabhi, R.M., Schmaltieg, A., Becerra, C. and Gaynor, R.B. (2003) “Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells”, Clin. Cancer Res. 9, 1291–1300.
   PubMed Web of Science ®Google Scholar
• Vickers, T.A., Koo, S., Bennett, C.F., Crooke, S.T., Dean, N.M. and Baker, B.F. (2003) “Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis”, J. Biol. Chem. 278, 7108–7118.
   PubMed Web of Science ®Google Scholar
• Whitehouse, A. (2003) “Herpesvirus saimiri: a potential gene delivery vector (review)”, Int. J. Mol. Med. 11, 139–148.
   PubMed Web of Science ®Google Scholar
• Wickstrom, E. (1986) “Oligodeoxynucleotide stability in subcellular extracts and culture media”, J. Biochem. Biophys. Methods 13, 97–102.
   PubMedGoogle Scholar
• Williams, S.A. and Buzby, J.S. (2000) “Cell-specific optimization of phosphorothioate antisense oligodeoxynucleotide delivery by cat-ionic lipids”, Methods Enzymol. 313, 388–397.
   PubMed Web of Science ®Google Scholar
• Xu, Y., Zhang, H.Y., Thormeyer, D., Larsson, O., Du, Q., Elmen, J., Wahlestedt, C. and Liang, Z. (2003) “Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs”, Biochem. Biophys. Res. Commun. 306, 712–717.
   PubMed Web of Science ®Google Scholar
• Yang, D., Buchholz, F., Huang, Z., Goga, A., Chen, C.Y., Brodsky, F.M. and Bishop, J.M. (2002) “Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells”, Proc. Natl Acad. Sci. USA 99, 9942–9947.
   PubMed Web of Science ®Google Scholar
• Yoon, H.S., Chen, X. and Yang, V.W. (2003) “Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage”, J. Biol. Chem. 278, 2101–2105.
   PubMed Web of Science ®Google Scholar
• Zamore, P.D., Tuschl, T., Sharp, P.A. and Bartel, D.P. (2000) “RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals”, Cell 101, 25–33.
   PubMed Web of Science ®Google Scholar
• Zender, L., Hutker, S., Liedtke, C., Tillmann, H.L., Zender, S., Mundt, B., Waltemathe, M., Gosling, T., Flemming, P., Malek, N.P., Trautwein, C., Manns, M.P., Kuhnel, F. and Kubicka, S. (2003) “Caspase 8 small interfering RNA prevents acute liver failure in mice”, Proc. Natl Acad. Sci. USA 100, 7797–7802.
   PubMed Web of Science ®Google Scholar
• Zhang, D., Li, F., Weidner, D., Mnjoyan, Z.H. and Fujise, K. (2002) “Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone”, J. Biol. Chem. 277, 37430–37438.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Shan, P., Jiang, D., Noble, P.W., Abraham, N.G., Kappas, A. and Lee, P.J. (2004) “Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apopto- sis”, J. Biol. Chem. 279, 10677–10684.
   PubMed Web of Science ®Google Scholar